Endothelial progenitor cells in the host defense response
- PMID: 36436689
- PMCID: PMC9944665
- DOI: 10.1016/j.pharmthera.2022.108315
Endothelial progenitor cells in the host defense response
Abstract
Extensive injury of endothelial cells in blood vasculature, especially in the microcirculatory system, frequently occurs in hosts suffering from sepsis and the accompanied systemic inflammation. Pathological factors, including toxic components derived from invading microbes, oxidative stress associated with tissue ischemia/reperfusion, and vessel active mediators generated during the inflammatory response, are known to play important roles in mediating endothelial injury. Collapse of microcirculation and tissue edema developed from the failure of endothelial barrier function in vital organ systems, including the lung, brain, and kidney, are detrimental, which often predict fatal outcomes. The host body possesses a substantial capacity for maintaining vascular homeostasis and repairing endothelial damage. Bone marrow and vascular wall niches house endothelial progenitor cells (EPCs). In response to septic challenges, EPCs in their niche environment are rapidly activated for proliferation and angiogenic differentiation. In the meantime, release of EPCs from their niches into the blood stream and homing of these vascular precursors to tissue sites of injury are markedly increased. The recruited EPCs actively participate in host defense against endothelial injury and repair of damage in blood vasculature via direct differentiation into endothelial cells for re-endothelialization as well as production of vessel active mediators to exert paracrine and autocrine effects on angiogenesis/vasculogenesis. In recent years, investigations on significance of EPCs in host defense and molecular signaling mechanisms underlying regulation of the EPC response have achieved substantial progress, which promotes exploration of vascular precursor cell-based approaches for effective prevention and treatment of sepsis-induced vascular injury as well as vital organ system failure.
Keywords: Blood vasculature; Endothelial injury; Endothelial progenitor cells; Host defense; Injury repair; Microcirculation; Niche; Sepsis; Septic infection; Systemic inflammation.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest statement The authors declare that there are no conflicts of interest.
Figures
Similar articles
-
Mobilization of endothelial progenitor cells in sepsis.Inflamm Res. 2020 Jan;69(1):1-9. doi: 10.1007/s00011-019-01299-9. Epub 2019 Nov 22. Inflamm Res. 2020. PMID: 31758219 Review.
-
The bone marrow endothelial progenitor cell response to septic infection.Front Immunol. 2024 Apr 4;15:1368099. doi: 10.3389/fimmu.2024.1368099. eCollection 2024. Front Immunol. 2024. PMID: 38665923 Free PMC article.
-
Importance of β2AR elevation for re-endothelialization capacity mediated by late endothelial progenitor cells in hypertensive patients.Am J Physiol Heart Circ Physiol. 2021 Feb 1;320(2):H867-H880. doi: 10.1152/ajpheart.00596.2020. Epub 2020 Dec 24. Am J Physiol Heart Circ Physiol. 2021. PMID: 33356961
-
Erythropoietin promotes the protective properties of transplanted endothelial progenitor cells against acute lung injury via PI3K/Akt pathway.Shock. 2014 Oct;42(4):327-36. doi: 10.1097/SHK.0000000000000216. Shock. 2014. PMID: 25051281
-
[The role of endothelial progenitor cells in sepsis].Anaesthesist. 2007 May;56(5):423-8. doi: 10.1007/s00101-007-1183-z. Anaesthesist. 2007. PMID: 17443298 Review. German.
Cited by
-
The Long Telling Story of "Endothelial Progenitor Cells": Where Are We at Now?Cells. 2022 Dec 28;12(1):112. doi: 10.3390/cells12010112. Cells. 2022. PMID: 36611906 Free PMC article. Review.
-
Non-coding RNAs regulating endothelial progenitor cells for venous thrombosis: promising therapy and innovation.Stem Cell Res Ther. 2024 Jan 2;15(1):7. doi: 10.1186/s13287-023-03621-z. Stem Cell Res Ther. 2024. PMID: 38169418 Free PMC article. Review.
-
Melatonin and angiogenesis potential in stem cells.Stem Cell Res Ther. 2025 Aug 5;16(1):424. doi: 10.1186/s13287-025-04531-y. Stem Cell Res Ther. 2025. PMID: 40764577 Free PMC article. Review.
-
Endothelial progenitor cells in pregnancy-related diseases.Clin Sci (Lond). 2023 Nov 29;137(22):1699-1719. doi: 10.1042/CS20230853. Clin Sci (Lond). 2023. PMID: 37986615 Free PMC article. Review.
-
Human placenta-derived endothelial progenitor cells: an animal-free culture system for efficient expansion.Biol Res. 2025 Jul 2;58(1):44. doi: 10.1186/s40659-025-00625-2. Biol Res. 2025. PMID: 40605021 Free PMC article.
References
-
- Abadie Y, Bregeon F, Papazian L, Lange F, Chailley-Heu B, Thomas P, et al. (2005). Decreased VEGF concentration in lung tissue and vascular injury during ARDS. The European Respiratory Journal 25, 139–146. - PubMed
-
- Aepfelbacher M, & Essler M (2001). Disturbance of endothelial barrier function by bacterial toxins and atherogenic mediators: A role for Rho/Rho kinase. Cellular Microbiology 3, 649–658. - PubMed
-
- Aicher A, Zeiher AM, & Dimmeler S (2005). Mobilizing endothelial progenitor cells. Hypertension 45, 321–325. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical